Humanwell Healthcare (Group) Co Ltd (600079) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:Asia

Author(s):

Product Code:GDPH139473D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

42

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anesthetics, biological products, herbal medicines, CNS medicines, women's health, anti-infection drugs, medical devices, OTC medicines and other products. Humanwell also provides buflomedil hydrochloride injectable, pantoprazole sodium injectable, omeprazole sodium injectable, phloroglucinol injectable, and simvastatin capsules. The company produces products in the forms of injection, tablets, syrup, granules, capsules, and suspension. It has partnership with other research institutes for investments, commercial distribution and research and development. Humanwell is headquartered in Wuhan, China.

Humanwell Healthcare (Group) Co Ltd (600079)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Humanwell Healthcare (Group) Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Humanwell Healthcare (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Ambrx Raises USD45 Million in Venture Financing 13

Private Equity 15

AGIC Capital Acquires Ritedose From Olympus Partners 15

Licensing Agreements 17

Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 17

Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 18

Equity Offering 19

Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 19

Wuhan Humanwell Healthcare Plans Private Placement of Shares for up to USD412.5 Million 20

Wuhan Humanwell Hi-tech Industry Plans For Private Placement Of Shares For Up To USD 163 Million 21

Debt Offering 22

Humanwell Healthcare to Raise USD302 Million in Private Placement of Notes 22

Humanwell Healthcare Raises USD150.8 Million in First Tranche of 4.99% Public Offering of Notes Due 2018 23

Humanwell Healthcare to Raise USD296.81 Million in Commercial Paper Offering 24

Humanwell Healthcare Raises USD224 Million in Public Offering of Notes 25

Humanwell Healthcare Plans to Raise USD309 Million in Public Offering of Notes 26

Humanwell Healthcare to Raise up to USD155 Million in Public Offering of Bonds 27

Wuhan Humanwell Announces Public Offering Of Notes Due 2015 For USD 95 MIllion 28

Acquisition 29

CSL to Acquire Remaining 20% Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD102 Million 29

Humanwell Healthcare Sells Bio-Pharma Unit for USD53 Million 30

CSL Acquires 80% Equity Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD352 Million 31

Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 32

Humanwell Healthcare Acquires Epic RE Holdco for USD21 Million 34

Humanwell Healthcare Plans to Acquire 70% Stake in Chengdu Kanghong Pharma for USD53 Million 35

Humanwell Healthcare Plans to Sell Shenzhen Biotech Firm for USD36 Million 36

Humanwell Healthcare to Acquire Yichang Sanxia Pharmaceutical for USD71.06 Million 37

Humanwell Healthcare Plans to Acquire 70% Stake in Pharmaceutical Firm for USD40 Million 38

Humanwell Healthcare (Group) Co Ltd-Key Competitors 39

Humanwell Healthcare (Group) Co Ltd-Key Employees 40

Humanwell Healthcare (Group) Co Ltd-Locations And Subsidiaries 41

Head Office 41

Other Locations & Subsidiaries 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42


List of Figure

List of Figures

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Humanwell Healthcare (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List of Table

List of Tables

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Humanwell Healthcare (Group) Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Humanwell Healthcare (Group) Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Humanwell Healthcare (Group) Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Ambrx Raises USD45 Million in Venture Financing 13

AGIC Capital Acquires Ritedose From Olympus Partners 15

Elite Pharma Enters into Licensing Agreement with Epic Pharma for Abuse-Deterrent ELI-200 17

Elite Pharma Enters Into Licensing Agreement With Epic Pharma For Twelve Generic Products 18

Humanwell Healthcare Decreases Size of Private Placement of Shares for USD174 Million 19

Wuhan Humanwell Healthcare Plans Private Placement of Shares for up to USD412.5 Million 20

Wuhan Humanwell Hi-tech Industry Plans For Private Placement Of Shares For Up To USD 163 Million 21

Humanwell Healthcare to Raise USD302 Million in Private Placement of Notes 22

Humanwell Healthcare Raises USD150.8 Million in First Tranche of 4.99% Public Offering of Notes Due 2018 23

Humanwell Healthcare to Raise USD296.81 Million in Commercial Paper Offering 24

Humanwell Healthcare Raises USD224 Million in Public Offering of Notes 25

Humanwell Healthcare Plans to Raise USD309 Million in Public Offering of Notes 26

Humanwell Healthcare to Raise up to USD155 Million in Public Offering of Bonds 27

Wuhan Humanwell Announces Public Offering Of Notes Due 2015 For USD 95 MIllion 28

CSL to Acquire Remaining 20% Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD102 Million 29

Humanwell Healthcare Sells Bio-Pharma Unit for USD53 Million 30

CSL Acquires 80% Equity Stake in Wuhan Zhong Yuan Rui De Biological Products from Humanwell Healthcare Group for USD352 Million 31

Humanwell Healthcare and PuraCap Pharma Acquire 100% Stake in Epic Pharma 32

Humanwell Healthcare Acquires Epic RE Holdco for USD21 Million 34

Humanwell Healthcare Plans to Acquire 70% Stake in Chengdu Kanghong Pharma for USD53 Million 35

Humanwell Healthcare Plans to Sell Shenzhen Biotech Firm for USD36 Million 36

Humanwell Healthcare to Acquire Yichang Sanxia Pharmaceutical for USD71.06 Million 37

Humanwell Healthcare Plans to Acquire 70% Stake in Pharmaceutical Firm for USD40 Million 38

Humanwell Healthcare (Group) Co Ltd, Key Competitors 39

Humanwell Healthcare (Group) Co Ltd, Key Employees 40

Humanwell Healthcare (Group) Co Ltd, Subsidiaries 41

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022